The complete amino acid sequence for the type I isozyme of hexokinase from rat brain has been deduced from the nucleotide sequence of cloned cDNA. The nucleotide sequence of 91 bases in the 5' untranslated region as well as that of the entire 3' untranslated region preceding the poly(A) sequence have also been determined. The N-and C-terminal halves of brain hexokinase show extensive sequence similarity to each other and to yeast hexokinase. These results provide direct support for the proposal that the mammalian hexokinases of -100 kDa have evolved by a process of duplication and fusion of a gene encoding an ancestral hexokinase similar to the yeast enzyme of -50 kDa. Taking this similarity in sequence to indicate basic similarity in structure between the N-and Cterminal regions of brain hexokinase and the yeast enzyme, a proposed structure for the mammalian hexokinase has been developed by fusing two molecules of yeast hexokinase, whose structure has previously been determined by x-ray crystallographic studies. Various features of the model are shown to be consistent with experimental observations bearing on the structure of the brain enzyme.
ABSTRACT
The complete amino acid sequence for the type I isozyme of hexokinase from rat brain has been deduced from the nucleotide sequence of cloned cDNA. The nucleotide sequence of 91 bases in the 5' untranslated region as well as that of the entire 3' untranslated region preceding the poly(A) sequence have also been determined. The N-and C-terminal halves of brain hexokinase show extensive sequence similarity to each other and to yeast hexokinase. These results provide direct support for the proposal that the mammalian hexokinases of -100 kDa have evolved by a process of duplication and fusion of a gene encoding an ancestral hexokinase similar to the yeast enzyme of -50 kDa. Taking this similarity in sequence to indicate basic similarity in structure between the N-and Cterminal regions of brain hexokinase and the yeast enzyme, a proposed structure for the mammalian hexokinase has been developed by fusing two molecules of yeast hexokinase, whose structure has previously been determined by x-ray crystallographic studies. Various features of the model are shown to be consistent with experimental observations bearing on the structure of the brain enzyme.
Hexokinase (ATP:D-hexose 6-phosphotransferase, EC 2.7.1.1) catalyzes the phosphorylation of glucose using MgATP as phosphoryl donor. In mammalian tissues, there are three isozymes of "low Km" hexokinase, commonly referred to as types I, II, and III (reviewed in ref. 1) . These isozymes have several properties in common, including a Km for glucose in the submillimolar range and a marked sensitivity to inhibition by the product glucose 6-phosphate; the latter is generally accepted as being a major factor in regulation of hexokinase activity, although additional factors may be involved (1) . Isozymes I-III are also similar in that they consist of a single polypeptide chain of --100 kDa. These properties contrast with those of a fourth type of hexokinase found in mammalian liver and pancreas, called type IV or, more commonly, "glucokinase." The latter enzyme is similar to the hexokinase found in yeast, consisting of a single polypeptide chain of -50 kDa and being insensitive to inhibition by physiologically relevant levels of glucose 6-phosphate. Such comparisons led several investigators (2) (3) (4) (5) (6) (7) to suggest that the mammalian isozymes I-III might have evolved by a process involving duplication and fusion of a gene encoding an ancestral hexokinase similar to present-day glucokinase and yeast hexokinases.
According to this scenario, one of the catalytic sites in the fusion protein evolved to take on regulatory function while the other retained its catalytic role. The location of catalytic function in the C-terminal half (8, 9) and the regulatory site for glucose 6-phosphate in the N-terminal half (10) of the type I isozyme from rat brain is consistent with this proposal.
Furthermore, there is now direct evidence for similarity in the amino acid sequence of mammalian and yeast hexokinases (11) (12) (13) . Two groups (14, 15) have cloned the genes for yeast isozymes A and B, which differ only slightly in their deduced amino acid sequence. More recently, we have cloned and sequenced a cDNA encoding the entire Cterminal half of the rat brain enzymes (13) , in which catalytic function resides (8, 9) . Comparison of the deduced amino acid sequence with that of yeast hexokinase demonstrated extensive similarities in sequence, including retention of several residues that, based on x-ray crystallographic studies of the Steitz laboratory (16) , are thought to be important in binding of the substrate glucose. Also conserved are several residues proposed to be involved in binding of MgATP (13) .
Here we describe the isolation and sequencing of cDNA clones providing the entire sequence of rat brain hexokinase.* Thus, it has become possible to directly test another prediction based on the proposed evolutionary pathwaynamely, that extensive sequence similarity will exist between the N-and C-terminal regions of a "low Km" mammalian hexokinase. This is shown to be the case. Perhaps more importantly, the similarity in sequence can reasonably be presumed to indicate an overall conservation of secondary and tertiary structure (17) (18) (19) (20) . We propose a specific structure for the mammalian enzyme based on that of yeast hexokinase (16, (21) (22) (23) . Certain existing experimental observations are shown to be consistent with the proposed structure, which should prove useful in planning and analysis of future experiments aimed at elucidation of structure-function relationships in mammalian hexokinases.
MATERIALS AND METHODS
Total RNA was isolated from adult rat brains and poly(A) mRNA selected on oligo(dT)-cellulose as described (24) . A rat brain cDNA library was constructed in AgtlO following the procedure of DeWitt and Smith (25) . Northern blot analysis and plaque hybridizations were performed as described by Maniatis et al. (26) using as probe the previously described (13) clone, designated HKI 12.4-4 and corresponding to the sequence in the C-terminal half of the molecule. DNA was isolated from positive recombinant phage (27) and cloned into M13mpl8 for sequencing. Nonrandom deletions were generated as described by Henikoff (28, 29) and were sequenced by the dideoxynucleotide chain-termination method (30) . Rat brain hexokinase was subjected to limited digestion with trypsin as described by Polakis and Wilson (31) . Under these conditions, in which native structure of the enzyme is preserved, cleavage occurs primarily at two sites, previously designated T1 and T2; this gives rise to fragments of 10, 50, and 40 kDa, which correspond to extreme N-terminal, more *The sequence reported in this paper is being deposited in the EMBL/GenBank data base (accession no. J04526).
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Fig. 3 ,49% of the amino acid residues are identical and 17% are conservative substitutions when the Ned from HKI 1.4-7 and and C-terminal sequences are compared. Such remarkable the deduced amino acid internal sequence similarity, in conjunction with the obvious educed sequence match similarity to yeast hexokinase, clearly supports the proposal Sing of the protein or (2-7) that this mammalian hexokinase represents the product initiating methionine, a of duplication and fusion of a gene encoding an ancestral hexokinase of =50 kDa.
Secondary structural features of yeast hexokinase were identified by the algorithm intrinsic to the MOSAIC program; these are shown beneath the corresponding amino acid sequences in Fig. 3 . Several of the insertions or deletions that have occurred in the course of evolution of yeast and -*mammalian hexokinases from their common ancestor correTaq I Taq I EcoRI spond to surface regions that are devoid of, or near the ends * of, identified secondary structure. Frequently, such changes can be accommodated with minimal disruption of overall structure (17, 34 (The first three nucleotides in the previously reported sequence were derived from the EcoRI linker but had been mistakenly indicated as part of the coding sequence for hexokinase, an error corrected in the present report.) The deduced amino acid sequence for the N-terminal half of the molecule is indicated below the nucleotide sequence; regions corresponding to sequence determined directly from the protein are underlined. The presumed polyadenylylation signal (32) in the 3' region is also underlined. the latter would surely be significantly affected by the noted differences.
Residues corresponding to the catalytically important (16, (21) (22) (23) 35) Ser-158, Asn-210, Asp-211, Glu-269, and Glu-302 of yeast hexokinase, as well as residues proposed to be important in binding of MgATP (13) , are all found at equivalent positions in the sequence of both N-and C-terminal halves of the brain enzyme, despite evidence suggesting that catalytic activity is restricted to the C-terminal half (8) (9) (10) . Such extensive conservation of these residues in a region of the molecule no longer serving catalytic function seems surprising and suggests that they may play additional roles. An alternative but more complicated interpretation might be that the C-terminal half represents the site of the initial catalytic event, and thus the primary site of labeling when reactive substrate analogs are added individually (8, 9) , but that resulting conformational changes induce a catalytically competent structure in the N-terminal half-i.e., although only one-half would be active at a given time, the N-and C-terminal halves may alternate as functional catalytic sites, a reciprocating mechanism that is, in some respects, analogous to the "half of the sites reactivity" seen with some oligomeric enzymes (36) .
The alignment in Fig. 3 suggests that the C-terminal half of brain hexokinase lacks the sequence corresponding to the N-terminal segment and first helix of the yeast enzyme. We have generated a model of the mammalian enzyme (Fig. 4) , based on the x-ray structure of the yeast enzyme (16, (21) (22) (23) , by fusing the C terminus of one complete yeast hexokinase molecule with a second, truncated molecule lacking this region and then rotating the now-joined molecules to eliminate steric conflict while retaining sufficient proximity to permit noncovalent interactions between them. There was surprisingly little latitude in permissible alignments, and thus the model presented is far from arbitrary despite the somewhat subjective manner in which it was generated. It should be noted here that the first 20 residues of the yeast sequence could not be located by Steitz and coworkers (16, Several features of this model are consistent with existing experimental results. For example, brain hexokinase binds to the outer mitochondrial membrane via a hydrophobic Nterminal sequence (33) , which inserts into the membrane (37) . It is apparent that the flexible N-terminal peptide segment, mentioned above, would be well suited to serve in tethering the enzyme to the mitochondrial membrane, and the protrusion of this segment from the enzyme's surface is consistent with its notable susceptibility to proteolytic attack (33) . The absence of hydrophobic character in this segment of the yeast enzyme accounts for the inability of yeast hexokinase to bind to mitochondria (38) ; there is precedent for evolution of functionally important, hydrophobic N-terminal segments from nonhydrophobic precursor sequences (39, 40) .
If the two halves of the enzyme exist in similar conformations, it might be expected that the tryptic cleavage sites, T1 and T2 (31) , are located in analogous positions in the N-and C-terminal halves. This is the case. Direct sequencing of the resulting fragments indicates that T1 and T2 correspond to cleavage at Lys-101 and Arg-551, respectively, which are found at virtually identical positions in the aligned N-and C-terminal sequences (Fig. 3) . Based on assumed structural similarity to the yeast enzyme, these residues are in, or near, p-turns at the surface of the molecule, and hence their marked sensitivity to tryptic attack is consistent with their location in the proposed structure (Fig. 4) .
The N-and C-terminal regions of brain hexokinase interact strongly by noncovalent forces, so much so that even after cleavage by trypsin, the resulting fragments remain tightly associated with retention of properties characteristic of the intact enzyme (31) . However, in 0.6 M guanidine hydrochloride, these interactions appear to be greatly weakened and a new tryptic cleavage site, designated T3 and located approximately in the middle of the molecule, is revealed (10 (Fig. 2) , and aligned beneath it is the corresponding sequence as deduced for the C-terminal half (13 Hence, manifestation of T3 under these conditions is confrom the point at which the N-and C-terminal halves are sistent with its location in the proposed structure.
fused. Based on the proposed structure (Fig. 4) , this site is It is apparent that the structure shown in Fig. 4 yeast structure (16) are not yet available through the Brookhaven data base, although these are not likely to result in any major changes from the structure proposed earlier by Steitz and colleagues (21) (22) (23) , upon which the present model for the mammalian hexokinase is based. Despite its limitations, we believe that the proposed structure is a reasonable one, developed on a rational basis and consistent with extant information, and that it will prove useful in the design and interpretation of future experiments aimed at elucidation of structure-function relationships in brain hexokinase and in other mammalian hexokinases.
Note. After this manuscript was submitted, Nishi et al. (41) reported the complete deduced amino acid sequence for the type I isozyme of human hexokinase. There is 92% identity between the sequences of the rat and human enzymes. Still more recently, Andreone et al. (42) reported the deduced sequence for the type IV isozyme ("glucokinase") from rat. Rat glucokinase shows 51% identity with the sequence of the C-terminal half of the rat type I isozyme (using a slightly different alignment, Andreone et al. calculated 53% identity) and 47% identity with the sequence of the N-terminal half.
